BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,275,000 | -53.6% | 3,181,000 | -52.4% | 0.00% | -50.0% |
| Q2 2018 | $7,062,000 | +3.2% | 6,680,000 | -0.2% | 0.01% | 0.0% |
| Q1 2018 | $6,842,000 | +78.9% | 6,693,000 | +97.7% | 0.01% | +100.0% |
| Q1 2017 | $3,824,000 | +0.1% | 3,386,000 | -0.9% | 0.00% | 0.0% |
| Q4 2016 | $3,822,000 | +2259.3% | 3,418,000 | +2431.9% | 0.00% | – |
| Q3 2016 | $162,000 | -85.7% | 135,000 | -86.2% | 0.00% | -100.0% |
| Q1 2016 | $1,129,000 | +7.1% | 975,000 | +18.8% | 0.00% | 0.0% |
| Q4 2015 | $1,054,000 | -89.9% | 821,000 | -89.8% | 0.00% | -90.0% |
| Q3 2015 | $10,436,000 | +119.6% | 8,078,000 | +162.0% | 0.01% | +150.0% |
| Q2 2015 | $4,752,000 | +108.6% | 3,083,000 | +101.4% | 0.00% | +100.0% |
| Q1 2015 | $2,278,000 | +206.6% | 1,531,000 | +142.2% | 0.00% | +100.0% |
| Q4 2014 | $743,000 | -6.3% | 632,000 | -15.6% | 0.00% | 0.0% |
| Q3 2014 | $793,000 | +28.1% | 749,000 | +25.3% | 0.00% | 0.0% |
| Q2 2014 | $619,000 | +321.1% | 598,000 | +330.2% | 0.00% | – |
| Q4 2013 | $147,000 | – | 139,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|